Oral 5-alpha-reductase inhibitors do not increase the risk for cardiovascular disease in patients treated for androgenetic ...
Regeneron (REGN) has exclusive opportunity to connect large-scale genomic and proteomic data cohorts to TriNetX's industry-leading global network of electronic health record data Collaboration will ...
Racial disparities in major adverse cardiovascular and cerebrovascular events outcomes among hospitalized cholangiocarcinoma patients.
Comparative outcomes of abiraterone and androgen receptor inhibitors (ARPIs) in metastatic castration-sensitive prostate cancer (mCSPC): A real-world analysis from the TriNetX database. This is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results